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Abstract. The calciuric response after an oral calcium
load (lOOOmg elemental calcium together with a
standard breakfast) was studied in 13 healthy male
controls and 21 recurrent idiopathic renal calcium
stone formers, 12 with hypercalciuria (UCax
V>7.50 mmol/24h) and nine with normocalciuria.
In controls, serum 1,25(OH)2 vitamin D3 (calcitriol)
remained unchanged 6 h after oral calcium load
(50.6 + 5.1 versus 50.9 + 5.0 pg/ml), whereas it tended
to increase in hypercalciuric (from 53.6 + 3.2 to
60.6 + 5.4 pg/ml, P = 0.182) and fell in normocalciuric
stone formers (from 45.9 + 2.6 to 38.1+3.3 pg/ml,
P = 0.011). The total amount of urinary calcium
excreted after OCL was 2.50 + 0.20 mmol in con-
trols, 2.27 + 0.27 mmol in normocalciuric and 3.62 +
0.32 mmol in hypercalciuric stone formers (P = 0.005
versus controls and normocalciuric stone formers
respectively); it positively correlated with serum calci-
triol 6h after calcium load (r = 0.392, P=0.024).
Maximum increase in urinary calcium excretion rate,
ACa-Emax, was inversely related to intact PTH levels
in the first 4 h after calcium load, i.e. more pronounced
PTH suppression predicted a steeper increase in urinary
calcium excretion rate. Twenty-four-hour urine calcium
excretion rate was inversely related to the ratio of A
calcitriol/APTHmax after calcium load (r = -0.653, P =
0.0001), indicating that an abnormally up-regulated
synthesis of calcitriol and consecutive relative PTH
suppression induce hypercalciuria. Finally, late absorp-
tion of calcium as suggested by maximum urinary
calcium excretion beyond 4 h after oral calcium load
was as rare in hypercalciuric stone formers (2 of 12)
as in controls (1 of 13) and did not occur in normo-
calciuric stone formers.
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Introduction
Idiopathic hypercalciuria can be found in about 50%
of patients with calcium nephrolithiasis and 5% of
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normal people [1,2]. A number of studies performed
in the past (reviewed in [3]) provided evidence for
elevated serum levels of 1,25 (OH )2 vitamin D3(calcitriol) as the primary event for idiopathic hyper-
calciuria. At least two mechanisms have been invoked
to account for this finding: an inherited abnormality
of the proximal tubular cell leading to up-regulation of
calcitriol synthesis in hypercalciuric calcium stone
formers (HCSF) (reviewed in [3]), or an increased
monocytic production of interleukin 1 leading to a
prostaglandin-mediated rise in calcitriol synthesis [4].
Increased calcitriol levels appear to predispose to
hypercalciuria by raising intestinal calcium absorption.
Indeed, the rise in urinary calcium excretion within 4 h
after an oral calcium load (OCL) directly correlated
with increased calcitriol levels in HCSF, when studied
after 10 days on a low-calcium diet [5], and the
calciuric response after OCL was also correlated with
isotopic fractional intestinal absorption of calcium
[6,7].
Hypercalciuria raises urinary supersaturation, which
is a prerequisite for calcium stone formation in the
urinary tract [8,9]. Commonly, however, supersat-
uration is intermittent throughout a 24-h period [9];
thus normal 24-h excretion rates may not reflect periods
of intermittent urinary supersaturation, and the classic-
ally used 4-h post-calcium-load excretory rates may be
too short for that purpose.
The present 6-h calcium load study has been designed
(1) to assess calcium metabolism for 6 h after OCL in
HCSF, normocalciuric calcium stone formers (NCSF)
and controls (C) while on free-choice diet; and (2) to
test the hypothesis of occurrence of delayed intermit-
tent hypercalciuria after OCL (late absorbers).
Subjects and methods
Among the patients seen for metabolic work-up at our renal
stone clinic, we selected 21 male recurrent calcium stone
formers (RCSF) meeting the following criteria: (1) passage
of at least two calcium-containing stones, defined either by
stone analysis (X-ray diffraction or infrared spectroscopy)
or disappearance of opaque material on conventional radio-
graphs and excretory urograms; (2) true idiopathic calcium
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stone disease, i.e. exclusion according to the previously
published protocol [10] of established causes of calcium
stone formation such as primary hyperparathyroidism,
medullary sponge kidney, overt distal renal tubular acidosis,
sarcoidosis, excessive vitamin D intake, hypercalciuria due
to hypercalcaemia (malignancy or immobilisation), and prim-
ary or enteric hyperoxaluria; (3) plasma creatinine concentra-
tion < 115 umol/1); and (4) absence of urinary tract infection,
any renal disease other than nephrolithiasis, or bone disease.
All RCSF underwent our standard protocol for metabolic
evaluation not prior to 2 months after urological intervention
and while adhering to their individual free-choice diet, as
previously described [10]. Metabolic work-up consisted of
sampling fasting venous blood and 2-h urine after 12 h
without eating and 8 h without drinking (only tap water
allowed after last meal). Every patient collected two 24-h
urines. RCSF were interviewed by their physicians for dietary
habits only once both collections had been completed. This
is to avoid influencing dietary habits before urine collections
have been completed. An estimate of daily calcium intake
from dairy products was obtained using a questionnaire
based on dairy products regularly consumed in Switzerland
and a table of their calcium content [11].
All RCSF were kept on free-choice diet and underwent
the oral calcium loading study (OCL), as did 13 healthy
male volunteers without any evidence of kidney or bone
disease (C); additionally, nine of 13 C collected one 24-h
urine while adhering to their free-choice diet. Informed
consent was obtained from every participant before OCL.
On the evening prior to the study, subjects were not allowed
to eat later than at 7.00 p.m. Until midnight, they drank
0.5 1 of tap water. On the morning of the study day, subjects
voided the bladder at 6.00 a.m. and remained fasting. After
arriving at the Clinical Investigation Unit of the Policlinic
of Medicine at 8.00 a.m., an indwelling catheter was placed
in an antecubital vein, from where fasting blood was drawn,
and 2-h fasting urine was collected. Thereafter, subjects
received a standard breakfast (130 g dark bread, 40 g butter,
50 g jam) together with 1000 mg elemental calcium as cal-
cium-gluconolactate/calcium carbonate (Calcium-Sandoz ff,
Sandoz Pharmaceutical Company, Basle, Switzerland), given
as an effervescent solution in 0.5 1 of distilled water. Fifteen
and 30 min after breakfast had been ingested, blood was
drawn for measurements of ionized calcium and intact PTH.
Thereafter, blood and urine samples were collected hourly
during 6 h. Subjects remained recumbent except for voiding
the bladder every hour. They received 0.2 1 of distilled water
hourly throughout the study.
Plasma concentrations of creatinine, urea, total calcium,
phosphate, magnesium, sodium, potassium, chloride, uric
acid, albumin, and total protein were measured by autoana-
lyser techniques. In whole blood, ionized calcium was meas-
ured by an ion-selective electrode (Ciba-Corning Diagnostics
Corp., Medfield, MA, USA), and venous blood gas analysis
was performed by a Ciba-Corning 278 blood gas system
(Ciba-Corning Diagnostics) immediately after sampling with-
out compression. Intact PTH (normal values 10-65 pg/ml)
was measured in serum using an immunoradiometric assay
kit (Nichols Institute, San Juan Capistrano, CA, USA).
Serum 25(OH) vitamin D3 (25(OH)D3) and serum 1,25
(OH)2 vitamin D3 (Calcitriol) were also measured by immu-
noradiometric assays (Nichols Institute). Normal values,
obtained from 60 healthy volunteers (30 males, 30 females)
in the area of Berne, were 6-40 ng/ml for 25(OH)D3 and
25-79 pg/ml for calcitriol respectively.
Twenty-four hour as well as 2-h fasting urine samples were
analysed for calcium, phosphate, magnesium, sodium, potas-
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sium, chloride, uric acid, urea and creatinine by autoanalyser
techniques. Oxalate was measured after enzymatic oxidation
by oxalate oxidase [12], citrate using the citrate lyase method
[13], and sulphate by an HPLC system [14], as previously
described [10].
Urine pH was measured immediately after voiding using
a Metrohm 654 pH-Meter (Metrohm, Herisau, Switzerland).
Hydroxyproline (OHP) was measured using a kit (Hypro-
nosticon®, Organon Teknika, Boxtel, The Netherlands)
where OHP is coloured by Ehrlich's reagent and quantified
photometrically after binding to an acid cation exchange
resin, hydrolysis for 16 h and oxidation.
In 2-h fasting urines as well as in hourly urines after
calcium loading, urinary calcium output (mmol/period) was
calculated as [UQ,] x volume, and excretions of calcium as
well as OHP were expressed as Ca-E (= Uca/Uc.^ x
PCrea,mmol/l GF) and OHP-E (=U O H P /U C r c B xP C r a ,
umol/1 GF) respectively. Based on measurements in fast-
ing blood and 2-h fasting urine samples, renal phosphate
threshold (TmP/GFR) was derived from the nomogram of
Walton and Bijvoet [15].
Twenty-four hour urines were collected in 3-litre plastic
bottles containing 10 g of boric acid as a preservative agent
[10]. All individual 24-h urine values of RCSF are presented
as the mean of two urine collections. According to the
24-h urinary excretion rate of calcium ( U C a x V ) , RCSF
were divided into hypercalciurics (HCSF) and normo-
calciurics (NCSF); hypercalciuria was arbitrarily defined
as UCa x V>7.50 mmol/24, as originally described by
Hodgkinson and Pyrah [16].
All values are presented as means + SE. Non-parametric
Mann-Whitney U test for comparisons between single groups
and ANOVA for repeated measurements for inter-group
comparisons as well as simple regression analysis for correla-
tion studies were used.
Results
Table 1 summarizes the basal characteristics of all
study participants; among the 21 RCSF, 12 were
HCSF, and nine were NCSF. There was no significant
difference in calcium intake from dairy products
between HCSF and NCSF. Compared with both
HCSF and C, plasma creatinine concentration was
elevated in NCSF; however, it remained within the
normal range. For similar levels of ionized calcium,
Table 1. Basic characteristics of 34 subjects (C, HCSF and NCSF)
before OCL.
Age (years)
Ca intake (dairy
prod., mmol/d)
PCrea (umol/1)
Ca2+ (mmol/1)
PPh(mmol/l)
Intact-PTH (pg/ml)
25-OH-D3 (ng/ml)
Calcitriol (pg/ml)
C(13)
41.9 + 2.7
n.d.
92.9 + 3.1
1.28 + 0.01
0.96 + 0.04
25.7 + 2.1
21.2+1.5
50.6 ±5.1
NCSF (9)
44.9 + 2.3
18.2+1.6
104.6 + 2.9t
1.27 + 0.03
0.81 ±0.07
24.8 + 2.6
25.7±1.8
42.3 ±3.1
HCSF (12)
39.3 + 2.2
13.7±5.0
87.1+3.1*
1.27 + 0.01
0.86 + 0.05
23.1+2.6
22.6 ±2.0
56.3±4.0 +
Values are means + SEM. f/>=0.039 versus C; */>=0.005 versus
C.
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plasma phosphate, intact PTH and 25(OH)-vitamin
D3 between the three groups, serum calcitriol was
higher in HCSF than in NCSF.
Table 2 depicts the results of various measurements
in 2-h fasting urines. Compared with C, NCSF had
lower TmP/GFR values, whereas HCSF had high
fasting urinary excretion of calcium. Fasting OHP-E
as well as urinary oxalate/creatinine and sodium/creati-
nine concentration ratios were not different between
the three groups. Fasting Ca-E (r = 0.460, P = 0.006)
as well as fasting urinary Ca/Crea (r=0.393, P = 0.021)
were positively correlated with fasting urinary
Na/Crea. Fasting urinary Ca/Crea also correlated with
24-h urine Ca/Crea (r = 0.538, P=0.002). Moreover,
the total amount of calcium excreted in 2-h fasting
urines (mmol/2 h) positively correlated with baseline
calcitriol levels in RCSF (r = 0.508, P = 0.022).
Twenty-four-hour urine data are summarized in
Table 3. Urine volume (P<0.05) as well as 24-h urinary
excretion rates of calcium (P< 0.001) and of phosphate
(P< 0.025) were higher in HCSF than in C; the latter
parameter was also higher than in NCSF (P<0.05).
When the P/Crea ratio (mmol/mmol) was calculated,
no significant differences remained, either between
Table 2. Fasting urine measurements in 34 subjects (C, HCSF and
NCSF) before OCL
C(13) NCSF (9) HCSF (12)
Fasting UpH
TmP/GFR
(mmol/1 GF)
Fasting Ca-E
(umol/1 GF)
Fasting OHP-E
(umol/1 GF)
Fasting Ox/Crea
(umol/mmol)
Fasting Na/Crea
(mmol/mmol)
6.05 ±0.25
0.96 + 0.05
5.87 + 0.15
0.73 ±0.04*
6.03 ±0.26
0.87 + 0.05
0.023 + 0.002 0.024 ±0.005 0.035+ 0.004f
1.25±0.16 1.33±0.14 1.82±0.36
15.5 + 3.3 18.7±4.3 22.1 ±5.3
8.86 + 0.91 9.42±2.38 9.91 ±1.33
Values are means±SEM. f/>=0.039 versus C; *P = 0.005 versus
C.
Table 3. Twenty-four-hour urine measurements in C (available in
nine subjects), HCSF (n= 12) and NCSF (n = 9)
All values are in mmol/day (means ± SEM) except where otherwise
indicated. °P<0.05 versus C; t/><0.025 versus C; *P<0.05 versus
NCSF; **P<0.001 versus NCSF and versus C
HCSF (2.18 + 0.11) and C (2.18+0.13) or between
HCSF and NCSF (1.89 + 0.10, P=0.118). UCaxV
positively correlated with UNaxV (r = 0.389, P=
0.034). Whereas urinary creatinine excretion rates were
not different between subgroups, Ccrea amounted to
115.1+5.2 ml/min/1.73 m2 in HCSF, compared with
94.8+4.1 ml/min/1.73 m2 in NCSF (P=0.004).
After OCL, whole blood ionized calcium was at no
time significantly different between subgroups. Figure 1
represents the OCL-induced deviations from baseline
for mean Ca2+ and intact PTH concentrations in the
three subgroups. The increase in Ca2+ occurred first
in HCSF, followed by NCSF, and started only after
30min in C (Figure 1, upper panel). The difference
2 +
wasbetween Ca2+ at 1/2 h and at time 0, A Ca
 1/2_0,
higher in HCSF than in C (0.030 + 0.011 versus
0.001 ±0.010mmol/1, P = 0.046), whereas the value in
NCSF (0.017 + 0.018 mmol/1) was different neither
from HCSF nor from C. When considering deviations
of Ca2+ concentrations with time during the whole
360 min after OCL (areas under the curves), values
were 11.5 + 3.4 mmol/1 x min in C, 13.6 ±6.7 mmol/
1 x min in NCSF, and 13.8 + 3.9 mmol/1 x min in HCSF
(NS for all comparisons). During the first 60 min
after OCL, however, areas under the curves were
0.49+ 0.26 mmol/1 x min in C, 0.74 + 0.45 mmol/
lxmin in NCSF (P = 0.664 versus C), and
1.81+0.55 mmol/1 x min in HCSF (P = 0.054 versus
NCSF and P = 0.041 versus C).
o
2 3 4
hour* alter calolum loading
Volume (ml/day)
UaxV
UpxV
U U r e a xV
US u l fxV
U U A x V
Ucrea x V
\JO[ x V (umol/day)
UN axV
UMgxV
Uc i IxV
C
1318 + 202
4.8 + 0.6
28.9+1.7
399 + 39
21.4+1.1
3.2 + 0.3
13.5 + 0.9
274 + 59
193 + 31
4.2 + 0.5
3.3 + 0.5
NCSF
1995 ±229
5.2 + 0.4
29.2 + 2.2
437 + 26
20.7+1.3
4.1 ±0.3
15.4 + 0.8
339 + 39
224 + 21
4.0 + 0.5
2.6±0.2
HCSF
2033 + 229°
10.2 + 0.7**
35.3 +1.5f*
400 + 25
21.3 + 1.3
3.5 + 0.25
16.4 + 0.8
354 + 54
213 + 27
4.9±0.5
3.2±0.3
'm
l)
2
X
a.
o
- 2
-4
- 8
- 8
- 1 0
- 1 2
- 1 4
2 3 *
hours after calcium loading
*- Control! - * - HCSF - • - NCSF
(13) (12) (S)
Fig. 1. Mean deviations from baseline values of Ca2+ (upper panel)
and intact PTH (lower panel) after oral calcium load (1 g) in
controls (stars). NCSF (circles), and HCSF (triangles). Values are
means +SEM.
Oral calcium loading, PTH and calcitriol in stone formers
When using ANOVA for repeated measurements,
intergroup differences in serum intact PTH after OCL
were not significant. At 15 and 30min after OCL,
however, intact PTH was lower in HCSF (13.4 + 2.4
and 10.8 +1.6 pg/ml respectively) than in NCSF
(18.7 + 1.2 and 15.2+1.4pg/ml respectively, i><0.05
for both comparisons, Mann-Whitney U test). The
total deviation of intact PTH from baseline over
360 min (Figure 1, lower panel) was not different
between the three groups; areas under the curves
amounted to —3377.9 + 329.5 pg/ml x min in C,
-3291.9 + 557.3 pg/ml x min in HCSF, and
-2636.7 + 673.6 pg/ml x min in NCSF (NS for all
comparisons).
Serum calcitriol concentrations 6 h after OCL were
unchanged in C (50.6 + 5.1 pg/ml before versus
50.9 + 5.0 pg/ml after OCL), tended to increase in
HCSF (53.6 + 3.2 pg/ml before and 60.6 + 5.4 pg/ml
after OCL, P = 0.182) and fell in NCSF
(45.9+ 2.6 pg/ml before and 38.1 + 3.3 pg/ml after
OCL, P = 0.011). Thus after OCL, serum calcitriol
concentration in NCSF was lower than in C (P =
0.049) and in HCSF (P = 0.007). Deviations in serum
calcitriol concentrations from baseline values at 6 h
after OCL (A calcitriol) were 0.3 ±2.9 pg/ml in C,
-4.2+ 0.9 pg/ml in NCSF, and 4.3 + 3.5 pg/ml in
HCSF (P=0.028 versus NCSF). As depicted in
Figure 2, there was an inverse correlation between the
ratio A calcitriol/maximum change in PTH (A
calcitriol/APTHmax) and UCaxV (r = -0.653, P =
0.0001), i.e. those subjects in whom the increase in
calcitriol following OCL was steepest in the presence
of a marked fall in PTH were most hypercalciuric.
As demonstrated in Figure 3, hourly urinary calcium
excretion in the first 5 h after OCL was higher in
HCSF than in NCSF and in C (P<0.05 for all
comparisons, ANOVA for repeated measurements); in
y = -2.04x + 6.84, r = .653
12
oI 8
X
a 4
o
ZJ
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Fig. 2. Negative linear correlation ( r= —0.653, /"=0.0001) between
UG, x V (y axis) and A calcitriol/APTH^,,, ratio (x axis). A calci-
triol = change in calcitriol concentrations between before and after
OCL; APTHmai = maximum decrease in PTH concentrations follow-
ing OCL. Circles, C (4 missing values, since subjects did not collect
24-hour urines); crosses, NCSF; triangles, HCSF.
0.75
0.6
0.46
0,3
= 0,15
1 hour
C D C (13)
3 hr». 4 hr». 6 hn.
alter OCL (1 g)
• • HCSF (12) M NCSF (9)
Bhrt.
Fig. 3. Hourly urinary calcium output (mmol/period) after oral
calcium load (1 g) in controls, HCSF and NCSF. Values are means
+ SEM. °P<0.05; fPO.025; *P<0.005 versus HCSF.
the 6th hour after OCL, the difference remained signi-
ficant only for HCSF versus NCSF (P = 0.0l2), but
not for HCSF versus C. The total urinary calcium
output after OCL amounted to 3.62 + 0.32 mmol in
HCSF, compared with 2.50 + 0.20 mmol in C and
2.27 + 0.27 mmol in NCSF (P = 0.005 versus C and
NCSF respectively). It correlated positively with serum
calcitriol levels 6h after OCL (r = 0.392, P = 0.024),
but not with those before OCL (r = 0.309, P = 0.081)
nor with A calcitriol (r = 0.223, /> = 0.212).
Throughout the 6-h period after OCL, Ca-E differed
among the three groups (P — 0.004, ANOVA for
repeated measurements), i.e. HCSF excreted more cal-
cium than NCSF and C. However, the maximum
increase in Ca-E from baseline, A Ca-Emax, was similar
in all three groups, i.e. 0.057 + 0.005 umol/1 GF
in C, 0.052 + 0.008 umol/1 GF in NCSF, and
0.071 +0.010 umol/1 GF in HCSF (NS for all compar-
isons). Furthermore Ca-Emax tended to be inversely
related to baseline values of intact PTH (r=-0.336,
P = 0.052), and the increase in Ca-E during the first
hour after OCL also was inversely related to baseline
intact PTH levels (r= -0.348, P = 0.044), i.e. subjects
with lower PTH levels at baseline had steeper increases
in Ca-E. Table 4 depicts that A Ca-Emax inversely
correlated with intact PTH values during the first 4 h
after OCL.
Maximum hourly calcium excretion occurred during
the 2nd hour after OCL in six C; in two of the 13 C,
Table 4. Inverse linear correlations between A Ca-E,,^ and intact
PTH levels after oral calcium loading (OCL)
y axis
A Ca-E™,,
x axis
PTH1/4h
PTH1/2h
PTHl h
PTH2h
PTH3h
PTH4h
PTH5h
PTH6h
r value
-0.412
-0.419
-0.360
-0.440
-0.384
-0.388
-0.164
-0.307
P value
0.019
0.014
0.040
0.009
0.025
0.024
0.353
0.078
Subscripts denote time after OCL.
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however, maximum calcium excretion occurred later
than 4 h after OCL, i.e. during the 5th hour. Delayed
increases in urinary calcium excretion could not be
observed among the nine NCSF, of whom four had
their highest urinary calcium output during the 2nd
and three during the 3rd hour after OCL. Among the
12 HCSF, three had maximum calciuria already in the
1st hour after OCL, two in the 2nd, four in the 3rd,
and two in the 4th hour; thus, late hypercalciuria
occurred in only one of the 12 HCSF.
Discussion
The present study illustrates the fact that the magnitude
of calciuric response after OCL is related to the degree
of early parathyroid suppression and to post-load
calcitriol levels, when subjects are studied under free-
choice diet conditions.
Although OCL has originally been applied to distin-
guish between 'absorptive' and 'renal' types of idio-
pathic hypercalciuria [17], Coe et al. [18] convincingly
demonstrated that these two patterns are not distinct
entities, but rather two extremes of a continuous
spectrum. Therefore, we did not attempt to separate
'absorptive' from 'renal' hypercalciurics based on fast-
ing and post-load calciuria in this study, inasmuch as
available data (reviewed in [1] and [3]) clearly suggest
that the syndrome of idiopathic hypercalciuria always
includes features of both intestinal hyperabsorption
and reduced tubular reabsorption of calcium.
When comparing patterns of post-load blood cal-
cium concentrations among subgroups (Figure 1), it is
apparent that mean levels of blood ionized calcium
first rise in HCSF, then in NCSF, and ultimately (after
30 min) in C. In addition, calculations of areas under
the curve demonstrate that the cumulative deviation
of blood Ca2+ from baseline is greatest in HCSF only
during the first hour, but not when considering the
whole 6-h period after OCL that we studied. This
earlier increment in blood calcium in HCSF is matched
by lower PTH levels in these patients 15 and 30 min
after the calcium load. The fact that PTH secretion is
more suppressed in HCSF than in NCSF is in keeping
with our recent finding of relative hypoparathyroidism
in HCSF, compared with NCSF [10]. Parenthetically,
our study also emphasizes the fact that the availability
of the intact PTH assay has turned OCL into a
suppression test of parathyroid secretion, what in the
past had only indirectly been so by the mean of cyclic
AMP measurements.
It is noteworthy that basal serum calcitriol levels
were not predictive of the calciuric response after OCL
in our subjects on free-choice diet. This is at variance
with the findings obtained by Broadus et al. [5] who
demonstrated a positive correlation between post-load
calcium excretion and calcitriol levels when pooling
data from NCSF and RCSF with absorptive hypercal-
ciuria. Their specifically selected subjects, however,
were studied after at least 10 days on a calcium-
restricted diet (400 mg daily). Therefore calcitriol
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production had been stimulated by this manoeuvre, and
actually calcitriol levels clearly exceeded the upper
normal range in 40 of their 50 HCSF and were high-
normal in the other ones [5].
On the contrary, in the present study we deliberately
evaluated RCSF under conditions of stone formation,
i.e. while adhering to their free-choice diet. Therefore
none of our HCSF exhibits serum calcitriol values
above the upper limit of normal range (i.e. above
79pg/ml). Nevertheless, we confirm that calcitriol
levels are elevated in HCSF, when compared with
NCSF, which is consistent with data previously
obtained in many investigations (reviewed in [3]). In
addition we demonstrate that the calciuric response
after OCL inversely relates to serum PTH concentra-
tions, i.e. subjects with relative down-regulation of
PTH secretion excrete more calcium after OCL.
Together with the early increase in blood calcium that
we observe in HCSF after OCL, this finding is compat-
ible with an imbalance between calcitriol production
and PTH secretion, leading to the following sequence
of events: chronic up-regulation of calcitriol production
raises active intestinal calcium absorption which is
particularly marked in the duodenum [19]. The amount
of calcium being absorbed early in the duodenum will
be higher in subjects with elevated calcitriol levels,
which may explain the earlier increase in blood calcium
in HCSF; this in turn will lead to more pronounced
PTH suppression which increases urinary calcium
excretion.
In addition our study suggests a disordered control
of calcitriol synthesis in at least some HCSF [20,21],
compared to NCSF: despite an increase in blood
ionized calcium and a decrease in intact PTH concen-
trations, both changes which certainly should not
stimulate, but rather suppress calcitriol production
[22], mean calcitriol levels were unchanged or even
tended to rise 6 h after OCL in some HCSF, whereas
they fell in NCSF. In the past, a similar observation
has been reported by Broadus et al. [20] on a long-
term basis: when calcium intake was switched from
400 mg/day to 1000 mg/day in patients with absorptive
hypercalciuria, calcitriol fell after 3 days, but returned
to baseline values within 14 days. Our study demon-
strates that such an inappropriate regulation of calci-
triol synthesis contributes both to acute hypercalciuria
after OCL (as substantiated by the correlation between
total urinary output of calcium and calcitriol levels
after OCL), as well as to chronic hypercalciuria (as
demonstrated by the inverse relationship between
UCa x V and A calcitriol/APTHmax) (Figure 2).
Finally we find that the concept of late absorption
of calcium is more a myth than a reality: in only rare
subjects, maximum urinary calcium excretion occurred
later than 4 h after OCL. However, in these patients
this observation may be clinically relevant after intake
of a calcium-rich dinner, since urinary supersaturation
late at night and early in the morning, known periods
of increased urinary supersaturation [23], would rise
further.
In conclusion we demonstrate that the magnitude of
Oral calcium loading, PTH and calcitriol in stone formers
calciuric response after oral calcium loading depends
on both calcitriol production and PTH secretion. In
HCSF, secretion of the two calcotropic hormones is
in mutual imbalance, i.e. calcitriol production is in-
appropriately up-regulated with respect to blood
calcium, phosphate, and PTH levels. This induces
steeper increases in blood calcium early after calcium-
containing meals with more pronounced suppression
of PTH secretion and subsequent hypercalciuria.
Further studies are needed to better understand the
origin of this phenomenon.
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